Investigating the Potential of Adipose-Derived MSCs in Ocular GVHD Treatment

A study from Fujita Health University and Keio University explores the use of adipose-derived mesenchymal stromal cells (adMSCs) to reduce ocular inflammation and promote corneal tissue repair in GVHD.